Mark Oldakowski - 03 Jun 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
03 Jun 2025
Net transactions value
-$99.63
Form type
4
Filing time
03 Jun 2025, 18:59:01 UTC
Previous filing
18 Mar 2025
Next filing
12 Sep 2025

Sponsored

Quoteable Key Fact

"Mark Oldakowski filed Form 4 for Bionano Genomics, Inc. (BNGO) on 03 Jun 2025."

Quick Takeaways

  • This page summarizes Mark Oldakowski's Form 4 filing for Bionano Genomics, Inc. (BNGO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 03 Jun 2025, 18:59.

What Changed

  • Previous filing in this sequence was filed on 18 Mar 2025.
  • Current net transaction value: -$99.63.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OLDAKOWSKI MARK Chief Operating Officer C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO /s/ Jonathan V. Dixon, Attorney-in-Fact 03 Jun 2025 0001745566

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability $99.63 -27 -2.7% $3.69 974 03 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.